Meet the Oncology & Hematology Medical Consulting Team

Covance has a dedicated team of over 50 oncology physicians with an average of 23 years of industry and clinical experience, in countries across Europe, North America, Latin America and Asia. Covance physicians’ experience extend from translational/early phase development through product launch, late-phase/post marketing studies. Our medical team has been carefully selected based upon clinical, academic, and industry experience that cover the majority of oncology indications including pediatric oncology.

Within this Oncology medical team is a specialized team of Oncology medical consultants. This team provides expertise in life-cycle management of specific tumor indications including clinical development planning and strategy, establishment of target product profiles, program feasibility, risk assessment, and execution, registries, as well as program- and study-level medical oversight. They will share their collective expertise with you throughout your entire clinical journey to help you bring crucial treatments safely and efficiently to oncology patients.


Meet the Team

Ariel E. Aguiló, MD
Senior Medical Director

Ariel Aguiló, MD, Senior Medical Director for Covance Clinical Development Services in Buenos Aires, Argentina, is a board-certified oncologist specialized in gastrointestinal tumors. He provides subject matter expertise and support for the development and conduct of clinical trials on clients’ drug development projects, including serving as the company’s subject matter expert for Decentralized Clinical Trials (DCT). Dr. Aguiló performs medical monitoring on assigned projects, contributes to the medical strategy and execution of clinical programs, and brings scientific strategic leadership to the Oncology area at Covance. He has 10 years of experience as a physician, medical advisor and medical director in drug research and development. Before joining Covance, he served as Medical Director for Syneos Health in Buenos Aires, and prior to that, served as Medical Advisor for IQVIA in Buenos Aires. Dr. Aguiló began his career as Attending Physician, GI Oncology Department, Hospital de Gastroenterologia. He joined Covance in November 2019.

Ariel E. Aguiló, MD Senior Medical Director

Maria Ignacia Berraondo, MD
Senior Medical Director

Maria Ignacia Berraondo, MD, is Senior Medical Director for Covance Clinical Development Services, based in Buenos Aires, Argentina. She provides clinical and medical expertise to project teams and other Covance departments to advance clients’ drug development programs. Dr. Berraondo performs medical and safety monitoring on assigned projects; develops and reviews protocols, case report forms and other data and materials, and contributes to the scientific strategic leadership of the Oncology area at Covance. Dr. Berraondo has more than 10 years of experience in hematology and as a medical advisor and physician, with six years in clinical research, including as a director in clinical research and development. Before joining Covance, she served as Medical Director at IQVIA in Buenos Aires. Dr. Berraondo joined Covance in July 2020.

Maria Ignacia Berraondo, MD

Stefanella Bortini, PhD, MD
Senior Medical Director

Stefanella Bortini, MD, PhD, is Senior Medical Director, Oncology, for Covance Clinical Development Services, based in Milano, Italy. She contributes to the development of Covance policies involving medical, safety and therapeutics, and serves as global lead project physician on assigned projects. Dr. Bortini brings more than 30 years of experience in clinical research to Covance. Before joining the company, she was Senior Director, Medical Affairs, Oncology, for Chiltern International in Milan. She also has held positions with i3 Research, PRA International, Pharmacia & Upjohn, and Eli Lilly. Dr. Bortini is medically licensed by the Italian Board of Medical and Surgical Examiners and holds ECFMG Medical Certification for the U.S. She received her medical degree from the University of Firenze in Italy, and her PhD in Biomedical Engineering from Northwestern University. She joined Covance in July 2019.

Stefanella Bortini, PhD, MD Senior Medical Director

Begoña de las Heras Garcia, MD
Senior Medical Director

Begoña de las Heras Garcia, MD, is Senior Medical Director, Oncology, for Covance Clinical Development Services, based in Madrid, Spain. She is board certified Medical Oncologist, by La Paz hospital, Madrid, Spain.  Begoña joined Covance in 2016. She serves as project physician on clients’ drug development projects and provides medical/scientific expertise to project teams/business development teams. Also, she has line management activities of a group of MDs in the Oncology TA. She brings more than 20 years of national and international clinical oncology research experience to Covance. Before her current position, she served as Executive Medical Officer, Early Phase, for Chiltern in the UK. She also has held clinical research positions with Eisai in the UK and a several organizations in Spain including Pivotal CRO, Pharma Mar, AstraZeneca and Bristol-Myers Squibb. She also, was oncologist consult in several hospitals in Spain,  General Yagüe Hospital in Burgos,  Ntra Sra. Del Prado Hospital in Talavera de la Reina (Toledo) and La Paz Hospital in Madrid.

Begoña de las Heras, MD Senior Medical Director

Brian Hamilton, MD, PhD
Senior Medical Director

Brian Hamilton, MD, PhD, is Senior Medical Director for Covance Clinical Development Services, based in Newton, Massachusetts. He serves as Covance Subject Matter Expert for cellular immune-oncology, CAR-T and gene therapy. He also serves as global lead project physician on clients’ drug development projects. Dr. Hamilton has more than 35 years of experience in pediatric medicine, immunology, hematopoietic stem cell transplantation, and clinical research and development. Before joining Covance, he served as Executive Medical Monitor for Chiltern International. He has also held senior-level medical director, director physician, regulatory affairs and clinical research positions with Galena Biopharma, AstraZeneca, Onyx Pharmaceuticals, Wyeth Oncology, and other pharmaceutical and biotech firms. Dr. Hamilton joined Covance in August 2018.

Geoffrey Kannan, PhD, MD

He Huang, MD
Senior Medical Director

He Huang is Senior Director, Asia Pacific (APAC) for Covance Clinical Development Services, based in Shanghai, China.  He brings more than 10 years of experience as a physician and researcher in oncology, respiratory therapy and drug development to Covance. Before joining Covance, He served as Disease Area Head, Oncology/GI, for Bristol-Myers Squibb in Shanghai. He also served as Senior Manager, Respiratory, for AstraZeneca, and Medical Manager, Oncology/GI, for Roche, in Shanghai. He received the Global Champion and China CEO award at AstraZeneca. He began career as Medical Oncologist at Affiliated Hospital of Tongji Medical College of Huazhong University of Science and Technology in Wuhan, China. He joined Covance in September 2019.

He Huang, MD Senior Medical Director

Geoffrey Kannan, PhD, MD
Senior Medical Director

Geoffrey Kannan, PhD, MD, is a Senior Medical Director in the Oncology Therapeutic Area for Covance Clinical Development Services, based in Princeton, New Jersey. Dr. Kannan serves as global lead project physician on clients’ drug development projects, providing medical expertise and support in the development and conduct of clinical trials. Dr. Kannan brings more than 10 years of experience as a physician and medical director to Covance, specializing in oncology and pediatrics. Before joining Covance, he practiced as Pediatric Hematologist/Oncologist and Pediatric Neuro-oncologist, affiliated with Children’s National Medical Center. Prior to that, he served as Instructor of Pediatrics and Pediatric Neuro-oncologist for the Department of Pediatric Neuro-oncology, Dana-Farber Cancer Institute/Boston Children’s Hospital/Harvard Medical School. The author or co-author of many peer-reviewed journal articles, presentations and abstracts, Dr. Kannan joined Covance in November 2018.

Geoffrey Kannan, PhD, MD

Carlo Lanza, MD, PhD
Executive Medical Officer

Carlo Lanza, MD, PhD, is Executive Medical Officer for Covance Clinical Development Services, based in Lugano, Switzerland. Dr. Lanza performs medical monitoring and safety assessments on Phase 1-4 clinical trials for Covance clients. He leads early phase and translational research early development programs with targeted therapies, small molecules, biologics and gene therapy. Dr. Lanza also oversees development of late-stage development strategies, delivery and approval of registrational programs. He brings more than 20 years of experience in clinical research and development as a physician and medical director, specializing in pediatrics and oncology. Before joining Covance, he served as Medical Director for Medicines for Malaria Venture in Geneva, Switzerland. Dr. Lanza has also held leadership positions with Novartis Oncology, Pfizer Global R&D, and AstraZeneca UK. Carlo joined Covance in 2012.

Carlo Lanza, MD, PhD, MSc Executive Medical Officer

Maria Mateo, MD
Senior Medical Director

Maria Mateo, MD, is Senior Medical Director for Covance Clinical Development Services, based in Buenos Aires, Argentina. She provides clinical and medical expertise to project teams and other Covance departments to advance clients’ drug development programs. Dr. Mateo performs medical and safety monitoring on assigned projects; develops and reviews protocols, case report forms and other data and materials, and contributes to the scientific strategic leadership of the Oncology area at Covance. Dr. Mateo has more than 30 years of experience as a physician, clinical researcher, and medical director, previously holding positions with AMGEN, Boehringer-Ingelheim, IQVIA, IVAX Argentina, Syneos Health, Bristol-Myers Squibb and other drug development and health care organizations. Dr. Mateo joined Covance in November 2020.

Maria Mateo, MD

Martine Poelman, MD
Executive Medical Director

Martine Poelman is Executive Medical Director, Oncology, for Covance Clinical Development Services, based in Brussels, Belgium. She provides medical and scientific support to help advance drug development in hematological malignancies for Covance clients. Martine brings more than 30 years of experience in clinical research and development as a physician and medical director, specializing in pediatrics and oncology, to Covance. Before assuming her current position, Martine served more than 15 years as Global Head of Oncology Research for Covance, providing medical monitoring for more than 200 clinical trials. Before joining Covance, she served as Clinical Research Physician, Hemato-Oncology-Infectiology, for Eli Lilly in Brussels. Before going into research, she served as Bone Marrow Transplantation and Hemato-Oncology Physician for the Department of Pediatric Oncology, Wilhelmina Children’s Hospital, in The Netherlands. Martine joined Covance in November 1996.

Martine-Poelman-WEB

Kamal Veer Singh Saini, MD
Executive Medical Director

Kamal Veer Singh Saini, MD, is Executive Medical Director, Oncology, for Covance Clinical Development Services, based in Brussels, Belgium. Kamal is a board-certified medical oncologist, with an active license to practice in the UK. He contributes to the scientific strategic leadership of the Oncology area at Covance, and provides clinical and medical expertise to project teams and other Covance departments on clients’ drug development projects. Kamal brings more than 15 years of experience in clinical research and development to Covance. He previously served as Associate Scientific Director for an academic research organization and as Medical Advisor, Institute Jules Bordet, Brussels. The author or co-author of several peer-reviewed journal articles, Kamal joined Covance in June 2015.

Kamal Veer Saini

Ivana Teodorovic, MD
Senior Medical Director

Ivana Teodorovic, MD, is Senior Medical Director for Covance Clinical Development Services, based in Brussels, Belgium. Dr. Teodorovic serves as project physician and provides scientific support on global and regional oncology studies for Covance clients. She develops, reviews and revises protocols, and coordinates and performs medical monitoring and review of patient data. Dr. Teodorovic brings more than 30 years of experience as a physician and medical director in drug research and development. Before joining Covance, she served more than 10 years as Coordinating Physician for the European Organization for Research and Treatment of Cancer Data Center Company (EORTC) in Brussels, where she authored the SOP-EORTC Tissue Research Policy. Dr. Teodorovic began her career as a certified anatomopathologist at the Institute for Oncology and Radiology in Belgrade, Serbia. She joined Covance in May 2005.

Ivana Teodorovic, MD Senior Medical Director

Laura Vidal, MD
Executive Medical Director

Laura Vidal, MD, is Executive Medical Director for Covance Clinical Development Services, based in Madrid, Spain. Dr. Vidal is the Medical Head of the Oncology group in EU. She contributes to the development of Covance policies involving medical, safety and therapeutics; serves as point of contact for key clients on business oversight; manages relationships with investigators/sites for clinical trials, and mentors clinical research physicians and medical directors across the company. Dr. Vidal has more than 15 years of experience as a physician, clinical oncologist, and medical director. Before joining Covance, she was Executive Medical Director for Syneos Health in Madrid, and previously served as a physician, medical oncologist, and clinical trials coordinator for a hospital in Barcelona. Dr. Vidal has authored or co-authored dozens of peer-reviewed journal articles and received numerous health and research awards. She joined Covance in December 2020.

Laura Vidal, MD